Evidence map›Paper›PMID 39440935›Full record

ArticleThe Journal of infectious diseases2025

Coronavirus Disease 2019 Lineages in a Minimally Vaccinated Island Population: Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in Haiti.

Carla N Mavian, Massimiliano S Tagliamonte, Maclean Bassett, Meer T Alam, Melanie N Cash, Matt Hitchings, Rigan Louis, Alberto Riva, Kayvan Zainabadi, Marie Marcelle Deschamps and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Carla N MavianEmerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.ORCID 0000-0003-3819-5520
Massimiliano S TagliamonteEmerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.ORCID 0000-0003-2699-7331
Maclean BassettEmerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.ORCID 0000-0003-1964-7851
Meer T AlamEmerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.
Melanie N CashEmerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.ORCID 0000-0003-0144-7878
Matt HitchingsEmerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.ORCID 0000-0003-2327-3557
Rigan LouisEmerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.
Alberto RivaBioinformatics Core, Interdisciplinary Center for Biotechnology Research, University of Florida, Gainesville, Florida, USA.ORCID 0000-0001-9150-8333
Kayvan ZainabadiCenter for Global Health, Department of Medicine, Weill Cornell Medical College, New York, New York, USA.ORCID 0000-0003-3134-1783
Marie Marcelle DeschampsLes Centres GHESKIO, Port-au-Prince, Haiti.
Bernard LiautaudLes Centres GHESKIO, Port-au-Prince, Haiti.
Vanessa RouzierCenter for Global Health, Department of Medicine, Weill Cornell Medical College, New York, New York, USA.ORCID 0000-0002-9672-9474
Daniel W FitzgeraldCenter for Global Health, Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
Jean William PapeCenter for Global Health, Department of Medicine, Weill Cornell Medical College, New York, New York, USA.ORCID 0000-0002-2948-2774
J Glenn MorrisEmerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.ORCID 0000-0001-9347-1984
Marco SalemiEmerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.ORCID 0000-0003-0136-2102

Funding

Viable but Nonculturable MtbU19AI111143 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI GLICKMAN, MICHAEL HAGGAI, GLICKMAN, MICHAEL S · 2014 to 2020
$48.6M
Cross-reactivity of SARS-CoV-2 with coronaviruses isolated from humans in HaitiR21AI164007 · NIAID · UNIVERSITY OF FLORIDA · PI MORRIS, JOHN GLENN · 2021 to 2022
$419k
National Institute of Allergy and Infectious Diseases AI111143NIAID NIH HHS R21 AI164007NIAID NIH HHS U19 AI111143University of Florida Clinical and Translational Science InstituteUniversity of Florida Office of Research
6 · The paper itself

Abstract

We monitored severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in Haiti from 2020 to 2023. Despite Haitian coronavirus disease 2019 (COVID-19) travel restrictions and in the setting of a vaccination rate of 2.7%, the timing and lineage evolution of the Haiti epidemic mirrored what was occurring in the rest of the world. Sources for importation of lineages into Haiti were the United States, the Dominican Republic, Europe, and Brazil, with exportation of lineages to the United States, the Dominican Republic, Europe, and Asia. Viral loads in patients infected by the Delta and Omicron BA.1 variants were correlated along the phylogenies, suggesting that higher viral loads have facilitated strain transmission and evolution.

Indexed as

COVID-19SARS-CoV-2AdultCOVID-19 VaccinesFemaleGenome, ViralHaitiHumansMaleMiddle AgedPhylogenyVaccinationViral LoadCOVID-19 VaccinesHaitiSARS-CoV-2SARS-CoV-2 lineagesSARS-CoV-2 viral load

Identifiers

PMID39440935
PMCPMC11841648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.